VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$508.33
-8.11 (-1.57%)
Analyst Consensus
Strong Buy
37
Analysts
Very High
Coverage
Buy 30 81%
Hold 6 16%
Sell 1 3%
Price Target
Analyst Price Target -13.8% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $508.33
Current
$508.33
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-38.2%
Low target
Base Case
$438.34
-13.8%
Avg target
Bull Case
$454.41
+-10.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$533.67
-4.7% from high
52-Week Low
$362.50
+40.2% from low
50-Day SMA
$461.14
+10.2% vs SMA
200-Day SMA
$435.10
+16.8% vs SMA
RSI (14)
47.3
Neutral
Target vs 52W High
$438.34
-17.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.2%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.8%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.8%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.6%